News | Bertelsmann Investments | Gütersloh, 04/03/2025

Bertelsmann Investments Launches New Pharma-Tech Umbrella Company cormeo

• The new company combines the expertise of Pharma Tech companies Docuvera, EXTEDO and Rote Liste
• Further expansion of the Bertelsmann Next growth unit
• Carsten Coesfeld: “We underline with the launch of cormeo the high strategic relevance of the Pharma Tech growth market”

Gütersloh, April 03, 2025 – Bertelsmann Investments (BI) has founded the Pharma Tech holding company cormeo. The new holding combines the expertise of Docuvera, EXTEDO and Rote Liste under a shared umbrella. cormeo is part of Bertelsmann Next, the growth unit responsible for driving entrepreneurial development primarily in the growth sectors of Mobile Ad Tech (Applike), HR Tech (Embrace), and Pharma Tech (cormeo).

Carsten Coesfeld, CEO of Bertelsmann Investments, said: “Our Next growth program with its three focuses – Mobile Ad Tech, HR Tech, and Pharma Tech – is already making a relevant contribution to Bertelsmann’s growth through organic and acquisition-driven expansion. In the 2024 financial year, Next's organic growth was more than 130 percent. We are convinced of the potential of the Pharma Tech market. That's why we founded cormeo, underlining its high strategic relevance for Bertelsmann.”

Deniz Pielsticker, CFO of Bertelsmann Investments and responsible for the Next unit, added: “In recent years, we strongly advanced the entrepreneurial development and expansion of our Pharma Tech division through the acquisition of Rote Liste and EXTEDO as well as the investment in Docuvera. We will make significant investments in further growth in the coming years.”

The newly founded Pharma Tech holding cormeo aims to provide life sciences companies, health authorities, and healthcare professionals with a holistic approach to managing and sharing regulated information with a view to continuously improving patient health and care. By bringing together industry leaders Docuvera, EXTEDO, and Rote Liste, cormeo will promote synergies between its specialized brands and accelerate the development of groundbreaking, AI-powered solutions that optimize business processes and increase the efficiency of workflows.

Peter Koop, CEO of cormeo, said: “cormeo is combining the expertise of its brands Docuvera, EXTEDO and Rote Liste to offer industry and health authorities a Smart Information Lifecycle. This facilitates a seamless, multidirectional exchange of regulated information along the entire drug lifecycle – from early-stage clinical trials to actual patient care.”

Based on its strong international presence, cormeo plans to set new industry standards for the creation, management, and distribution of regulated information.

Alongside Peter Koop as cormeo’s CEO, the new holding’s management team will be composed of Tobias Beer (COO Authoring & Distribution), Martin Schmid (COO Information Management), Schei Dattner (CSO/CPO), Pia Danne (VP Finance), and Ina Glaser (VP Marketing).

About Bertelsmann Investments
Bertelsmann Investments (BI) comprises Bertelsmann’s global venture capital activities as well as the Bertelsmann Next growth unit. The venture capital arm includes the Bertelsmann Asia Investments (BAI), Bertelsmann India Investments (BII), and Bertelsmann Digital Media Investments (BDMI) funds, as well as selected fund and direct holdings in markets including Europe, the United States, Brazil, Southeast Asia and Africa. The Bertelsmann Next unit advances the entrepreneurial development of new growth sectors and business areas, including Digital Health, HR Tech, and Mobile Ad Tech. To date, around €1.9 billion has been invested in around 500 innovative companies and funds through Bertelsmann Investments. Bertelsmann Investments currently holds over 370 active investments worldwide through its network of start-ups and funds.

About cormeo
cormeo unites the expertise of Docuvera, EXTEDO, and Rote Liste to provide a seamless end-to-end approach to creating, managing, and distributing regulated information in the life sciences sector. Together, we build the trusted bridge between industry, authorities, healthcare professionals, and patients, facilitating the innovative and compliant exchange of regulated information in life sciences to improve patient health.

At the core of information creation, Docuvera transforms content creation, review, approval, and translation by providing a solution for AI-powered structured content authoring. In the sphere of information management, EXTEDO provides regulatory information and quality management solutions to industry and authorities that support the entire lifecycle of medicinal products. For information distribution, Rote Liste plays a vital role in distributing medical information to healthcare professionals and patients, empowering them to make informed decisions with confidence.

cormeo is shaping the future of life science information management. With our strong commitment to digital transformation, compliance, and patient health, we empower the life sciences industry to enhance efficiency and innovation. For more information, please visit https://www.cormeo.com